Sun Pharmaceutical Industries Ltd has clarified with reference to the news item which appeared on the "Website - www.moneycontrol.com" dated September 07,2018 captioned "Sun Pharma falls 5% on report of co getting 6 observations by US FDA for Halol unit".
The US FDA conducted a Pre-Approval Inspection (PAI) of Sun Pharmaceutical Industries Ltd.'s Halol facility (Gujarat, India) from August 27, 2018 to August 31, 2018. At the conclusion of the inspection, the agency issued a Form 483, with six observations. The Company will be submitting its response on the observations to the US FDA within 15 business days. Sun Pharma is committed to addressing these observations promptly.
Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.676.65 as compared to the previous close of Rs. 663.4. The total number of shares traded during the day was 492047 in over 8385 trades.
The stock hit an intraday high of Rs. 678.8 and intraday low of 663.65. The net turnover during the day was Rs. 330500494.